Scientists solve 3-D structure of cystic fibrosis protein in active, inactive states

October 19, 2018 by Mark Derewicz, University of North Carolina at Chapel Hill School of Medicine
Credit: University of North Carolina at Chapel Hill School of Medicine

Scientists at the UNC School of Medicine in collaboration with researchers at Oregon Health & Science University have resolved the three-dimensional molecular structure of the protein that's defective in people with cystic fibrosis in the protein's active and inactive state. The discovery, published in the journal Biochemistry, could open up new research avenues and help drug developers create enhanced pharmacotherapies to help people with CF.

Much of the biochemistry work was done in the lab of John Riordan, PhD, distinguished professor of biochemistry and biophysics at UNC-Chapel Hill. In the late 1980s, Riordan's lab discovered the mutated gene responsible for CF. If a child receives a copy of this faulty gene from each parent, the child will develop CF. The protein encoded by this gene was termed the transmembrane regulator, or CFTR, which is the chloride in epithelial cells that populate the respiratory system. People with CF lack a functional epithelial chloride channel, which is essential for maintaining the proper balance of salt and water in lungs and other organs.  One result of this is the production of thick, sticky mucus that becomes difficult to move out of the airways, leading to chronic infections and a shorter lifespan for most people with CF.

In the Riordan lab, postdoctoral fellow Jonathan Fay, PhD, led experiments using single-particle cryo-electron microscopy to discover the molecular structure of CFTR in the presence of ATP – a complex organic chemical necessary for many processes in cells, including a working chloride ion channel crucial for proper lung function. To help capture structures of the CFTR protein in its active and inactive state, the Riordan lab stabilized the CFTR protein such that the channel was off when dephosphorylated and locked-on when phosphorylated.   

Cryo-EM map of CFTR. Credit: University of North Carolina at Chapel Hill School of Medicine

These molecular structures reveal a unique repositioning of parts of the CFTR protein, providing insights into the structural transition between active and inactive functional states of CFTR.

Moreover, Fay and colleagues observed details of this complex that differ from what other scientists have discovered in previous CFTR structures.

"It is really amazing how much cryo-EM technologies have advanced and how using these techniques can allow us to visualize different states of the channel," Fay said. "I think our results are very exciting.  We discovered a new portal which presents a promising new area of the channel to target and control CFTR channel function."

And if researchers can successfully target and control the function of that channel, then they could create more precise therapies to better treat some people with CF.

Explore further: Scientists reveal new cystic fibrosis treatments work best in inflamed airways

More information: Jonathan F. Fay et al. Cryo-EM Visualization of an Active High Open Probability CFTR Anion Channel, Biochemistry (2018). DOI: 10.1021/acs.biochem.8b00763

Related Stories

Cystic fibrosis gene typo is a double whammy

November 12, 2010

An imbalance of salt and water in patients with cystic fibrosis makes their lungs clog up with sticky mucus that is prone to infection. The cause of the offending imbalance is a well-known genetic error, one that blocks the ...

New insights into functionality of cystic fibrosis protein

September 26, 2012

CFTR is an important protein that, when mutated, causes the life-threatening genetic disease cystic fibrosis. A study in The Journal of General Physiology (JGP) details how an accidental discovery has provided new understanding ...

Cancer gene plays key role in cystic fibrosis lung infections

December 12, 2017

PTEN is best known as a tumor suppressor, a type of protein that protects cells from growing uncontrollably and becoming cancerous. But according to a new study from Columbia University Medical Center (CUMC), PTEN has a second, ...

Recommended for you

Materials chemists tap body heat to power 'smart garments'

January 22, 2019

Many wearable biosensors, data transmitters and similar tech advances for personalized health monitoring have now been "creatively miniaturized," says materials chemist Trisha Andrew at the University of Massachusetts Amherst, ...

New synthesis method for producing fluorinated piperidines

January 22, 2019

Synthetic molecules are essential for many products, including medicines, crop protection agents and special materials such as Teflon. These molecules have several components, which can be combined in a variety of ways, resulting ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.